中国肿瘤医疗服务行业市场规模测算逻辑模型 头豹词条报告系列

Investment Rating - The report provides a positive investment rating for the oncology medical services industry, indicating a strong growth potential in the coming years [27]. Core Insights - The oncology medical services market in China is projected to grow significantly, with the market size expected to reach approximately 66.73 billion RMB by 2027, up from 33.15 billion RMB in 2018, reflecting a compound annual growth rate (CAGR) of around 10.32% [28][49]. - The report highlights the increasing number of cancer patients and the rising average treatment costs as key drivers for market growth [28][41]. - Public hospitals are expected to maintain a high patient acceptance rate, although a gradual decline is anticipated, from 96% in 2018 to 90% by 2027 [34][52]. Market Size Overview - The oncology medical services market size from 2018 to 2027 is detailed as follows: - 2018: 33.15 billion RMB - 2019: 36.86 billion RMB - 2020: 40.78 billion RMB - 2021: 45.25 billion RMB - 2022: 49.77 billion RMB - 2023E: 55.16 billion RMB - 2024E: 60.28 billion RMB - 2025E: 66.55 billion RMB - 2026E: 73.44 billion RMB - 2027E: 81.02 billion RMB [28]. Treatment Market Size - The oncology treatment market size is projected as follows: - 2018: 29.94 billion RMB - 2019: 32.67 billion RMB - 2020: 35.67 billion RMB - 2021: 38.97 billion RMB - 2022: 42.5 billion RMB - 2023E: 46.78 billion RMB - 2024E: 50.98 billion RMB - 2025E: 55.8 billion RMB - 2026E: 61.03 billion RMB - 2027E: 66.73 billion RMB [28][49]. Screening Market Size - The oncology screening market size is expected to grow as follows: - 2018: 3.21 billion RMB - 2019: 4.18 billion RMB - 2020: 5.1 billion RMB - 2021: 6.29 billion RMB - 2022: 7.27 billion RMB - 2023E: 8.38 billion RMB - 2024E: 9.3 billion RMB - 2025E: 10.75 billion RMB - 2026E: 12.41 billion RMB - 2027E: 14.29 billion RMB [28]. Average Treatment Costs - The average treatment costs are projected to increase from: - 2018: 66,200 RMB - 2019: 70,100 RMB - 2020: 74,300 RMB - 2021: 78,800 RMB - 2022: 83,500 RMB - 2023E: 89,400 RMB - 2024E: 94,700 RMB - 2025E: 100,400 RMB - 2026E: 106,400 RMB - 2027E: 112,800 RMB [39][41]. Patient Numbers - The number of oncology patients is expected to rise, with public hospital patient numbers projected as follows: - 2018: 4.15 million - 2019: 4.24 million - 2020: 4.33 million - 2021: 4.42 million - 2022: 4.51 million - 2023E: 4.61 million - 2024E: 4.7 million - 2025E: 4.78 million - 2026E: 4.85 million - 2027E: 4.93 million [37][41].